Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter June 8, 2013

A levothyroxine dose recommendation for the treatment of children and adolescents with autoimmune thyroiditis induced hypothyroidism

  • Victoria Ellerbroek EMAIL logo , Katharina Warncke , Julia Köhle and Walter Bonfig EMAIL logo

Abstract

Objective: To determine a levothyroxine (T4) dose recommendation for the treatment of autoimmune thyroiditis (AIT)-induced hypothyroidism.

Methods: T4 doses in 75 children and adolescents with newly diagnosed AIT were prospectively collected and compared to T4 doses of patients with congenital hypothyroidism (CH, n=22).

Results: Sixty-four patients with AIT and 22 patients with CH were included in the analysis. The thyroid-stimulating hormone declined significantly from 25.8±50.1 to 2.1±1.5 μIU/mL (AIT group; p<0.01) and from 338.7±380.7 to 1.9±1.6 μIU/mL (CH group; p<0.01). The required T4 dose for patients with AIT was 1.5±0.5 μg/kg per day (≥6 to <10 years: 2.0±0.4 μg T4/kg per day; ≥10 to <12 years: 1.6±0.4 μg T4/kg per day; ≥12 to <14 years: 1.5±0.6 μg T4/kg per day; ≥14 years: 1.4±0.6 μg T4/kg per day). It deviated significantly from the CH patients’ mean T4 dose of 2.8±0.7 μg T4/kg per day, p<0.01. CH patients with athyreosis required an average dose of 3.1±0.5 μg T4/kg per day; patients with ectopia, 2.6±0.7 μg T4/kg per day; and patients with dyshormonogenesis, 2.5±0.6 μg T4/kg per day.

Conclusion: Juvenile patients with AIT require significantly lower T4 doses than patients with CH.


Corresponding authors: Victoria Ellerbroek and Walter Bonfig, Department of Pediatrics, Children’s Hospital, Technical University of Munich, Parzivalstr. 16, 80804 München, Germany, Phone: +49 89 3068 2589, Fax: +49 89 3068 3849, E-mail: ;

References

1. Zois C, Stavrou I, Kalogera C, Svarna E, Dimoliatis I, et al. High prevalence of autoimmune thyroiditis in schoolchildren after elimination of iodine deficiency in northwestern Greece. Thyroid 2003;13:485–89.10.1089/105072503322021151Search in Google Scholar

2. Rallison ML, Dobyns BM, Meikle AW, Bishop M, Lyon JL, et al. Natural history of thyroid abnormalities: prevalence, incidence, and regression of thyroid diseases in adolescents and young adults. Am J Med Genet 1991;91:363–70.10.1016/0002-9343(91)90153-OSearch in Google Scholar

3. Gaudino R, Garel C, Czernichow P, Léger J. Proportion of various types of thyroid disorders among newborns with congenital hypothyroidism and normally located gland: a regional cohort study. Clin Endocrinol (Oxf) 2005;62:444–8.10.1111/j.1365-2265.2005.02239.xSearch in Google Scholar

4. Skordis N, Toumba M, Savva SC, Erakleous E, Topouzi M, et al. High prevalence of congenital hypothyroidism in the Greek Cypriot population: results of the neonatal screening program 1990–2000. J Pediatr Endocrinol Metab 2005;18:463–71.10.1515/JPEM.2005.18.5.453Search in Google Scholar

5. Rivkees SA, Bode HH, Crawford JD. Long-term growth in juvenile acquired hypothyroidism: the failure to achieve normal adult stature. N Engl J Med 1988;318:599–602.10.1056/NEJM198803103181003Search in Google Scholar

6. Rovet JF. Congenital hypothyroidism: long-term outcome. Thyroid 1999;9:741–8.10.1089/thy.1999.9.741Search in Google Scholar

7. Arbeitsgemeinschaft Pädiatrische Endokrinologie (APE) als Sektion der Deutschen Gesellschaft für Kinderheilkunde und Jugendmedizin (DGKJ) sowie der Deutschen Gesellschaft für Endokrinologie (DGE) Sektion Pädiatrische Endokrinologie und Diabetologie (2012). Leitlinie Autoimmunthyreoiditis. Available at: http://www.awmf.org/leitlinien/detail/ll/027-040.html.Search in Google Scholar

8. Brown RS. The thyroid. In: Brook C, Clayton P, Brown RS, editors. Brook’s clinical pediatric endocrinology, 6th ed. New York: Wiley-Blackwell, 2009:250–81.Search in Google Scholar

9. Latrofa F, Pinchera A. Autoimmune hypothyroidism. In: Weetman AP, editor. Autoimmune diseases in endocrinology, 12th ed. New Jersey: Humana Press, 2008:137–76.Search in Google Scholar

10. Deutsche Gesellschaft für Endokrinologie, Deutsche Gesellschaft für Kinder- und Jugendmedizin e.V., Arbeitsgemeinschaft Pädiatrische Endokrinologie. Diagnostik, Therapie und Verlaufskontrolle der Primären angeborenen Hypothyreose. Available at:http://www.awmf.org/leitlinien/detail/ll/027-017.html.Search in Google Scholar

11. Rose SR, Brown RS, Foley T, Kaplowitz PB, Kaye CI, et al. Update of newborn screening and therapy for congenital hypothyroidism. American Academy of Pediatrics and American Thyroid Association. Pediatrics 2006;117:2290–303.Search in Google Scholar

12. Taketomo CK, Hodding JH, Kraus DM, editors. Lexi-Comp’s pediatric dosage handbook with international trade names index: including neonatal dosing, drug administration, and extemporaneous preparations. American Pharmacist Association (APhA). Hudson, Ohio: Lexi-Comp, 2011.Search in Google Scholar

13. Fisher DA, Grueters A. Thyroid disorders in childhood and adolescence. In: Sperling M, editor. Pediatric endocrinology, 3rd ed. Philadelphia: Saunders/Elsevier, 2008:227–53.Search in Google Scholar

14. Van Vliet G. Hypothyroidism in infants, children and adolescents: Acquired hypothyroidism. In: Braverman LE, Utiger RD, editors. The thyroid: A fundamental and clinical text, 9th ed. Philadelphia: Lippincott Williams and Wilkins, 2005:1041–47.Search in Google Scholar

15. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003;13:3–126.10.1089/105072503321086962Search in Google Scholar

16. Roche Diagnostics GmbH. Reference intervals for children and adults: Elecsys thyroid tests. Mannheim, Germany, 2009.Search in Google Scholar

17. Mosteller RD. Simplified calculation of body surface area. N Engl J Med 1987;317:1098.10.1056/NEJM198710223171717Search in Google Scholar

18. De Fries L, Bulvik S, Phillip M. Chronic autoimmune thyroiditis in children and adolescents: at presentation and during long-term follow-up. Am J Dis Child 2008;94:33–7.10.1136/adc.2007.134841Search in Google Scholar

19. Abbassi V, Aldige C. Evaluation of sodium l-thyroxine (T4) requirement in replacement therapy of hypothyroidism. J Pediatr 1977;90:298.10.1016/S0022-3476(77)80656-2Search in Google Scholar

20. Rezvani IR, DiGeorge AM. Reassessment of the daily dose of oral thyroxine for replacement therapy in hypothyroid children. J Pediatr 1977;90:291.10.1016/S0022-3476(77)80655-0Search in Google Scholar

21. Gordon MB, Gordon MS. Variations in adequate levothyroxine replacement therapy in patients with different causes of hypothyroidism. Endocr Pract 1999;5:233–8.10.4158/EP.5.5.233Search in Google Scholar PubMed

22. Radetti G, Gottardi E, Bona G, Corrias A, Salardi S, et al. The natural history of euthyroid Hashimoto’s thyroiditis in children. J Pediatr 2006;149:827–32.10.1016/j.jpeds.2006.08.045Search in Google Scholar PubMed

23. Fava A, Oliverio R, Giuliano S, Parlato G, Michniewicz A, et al. Clinical evolution of autoimmune thyroiditis in children and adolescents. Thyroid 2009;19:361–7.10.1089/thy.2008.0239Search in Google Scholar PubMed

24. Özen S, Berk Ö, Simsek DG, Darcan S. Clinical course of Hashimoto’s thyroiditis and effects of levothyroxine therapy on the clinical course of the disease in children and adolescents. J Clin Res Pediatr Endocrinol 2011;3:192–7.10.4274/jcrpe.425Search in Google Scholar PubMed PubMed Central

Received: 2013-1-26
Accepted: 2013-5-14
Published Online: 2013-06-08
Published in Print: 2013-11-01

©2013 by Walter de Gruyter Berlin Boston

Downloaded on 26.4.2024 from https://www.degruyter.com/document/doi/10.1515/jpem-2013-0038/html
Scroll to top button